Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs.

Autor: Hope VD; Public Health Institute, Liverpool John Moores University, Liverpool, UK., McVeigh J; Department of Sociology, Manchester Metropolitan University, Manchester, UK., Begley E; Public Health Institute, Liverpool John Moores University, Liverpool, UK., Glass R; National Infection Service, Public Health England, London, UK., Edmundson C; National Infection Service, Public Health England, London, UK., Heinsbroek E; National Infection Service, Public Health England, London, UK., Kean J; NHS Greater Glasgow and Clyde, National Health Service Scotland, Glasgow, UK., Campbell J; Change Grow Live, Bradford, UK., Whitfield M; Public Health Institute, Liverpool John Moores University, Liverpool, UK., Morgan G; Commissioning Team, Cardiff and Vale University Health Board, Cardiff, UK., Acreman D; Substance Misuse Programme, Public Health Wales, Cardiff, UK., Smith J; Substance Misuse Programme, Public Health Wales, Cardiff, UK.
Jazyk: angličtina
Zdroj: Drug and alcohol review [Drug Alcohol Rev] 2021 May; Vol. 40 (4), pp. 586-596. Date of Electronic Publication: 2020 Nov 08.
DOI: 10.1111/dar.13198
Abstrakt: Introduction and Aims: Historically, people who inject image and performance enhancing drugs (IPED) were not perceived as being at high risk of HIV or hepatitis C virus (HCV) infection. However, recent studies indicate HCV and HIV prevalences are elevated, with many HCV infections undiagnosed.
Design and Methods: Men who inject IPEDs recruited from community settings and specialist services, including needle-syringe programs, across UK during 2016 self-completed a questionnaire. Multivariate analyses examined factors associated with HCV/HIV testing.
Results: The participants' (n=562; 24% service recruited) median age was 31 years, 4% identified as gay or bisexual, 18% had ever been imprisoned and 6% had ever injected a psychoactive drug. Those community recruited more often reported sharing drugs vials (16% vs. 8%, P=0.021) and, among those with 2+ sexual partners, poor condom use (50% vs. 36%, P=0.063), than those service recruited. Overall, one-third had ever been tested for HCV (31%) and/or HIV (34%). Testing uptake was associated with other risk factors for HCV/HIV, being recruited through services and having received metabolic tests. Participants' motivations for using IPEDs were associated with recruitment setting and HIV/HCV testing uptake.
Discussion and Conclusions: The majority were untested for HCV/HIV. HCV/HIV testing and risks were associated with recruitment through services. Previous needle and syringe program-based studies have potentially overestimated testing uptake and underestimated risk. Targeted interventions are needed, particularly for those not accessing services. The association between HCV/HIV testing uptake and receipt of metabolic tests suggests that developing a combined offer of these tests as part of health monitoring could improve uptake.
(© 2020 Australasian Professional Society on Alcohol and other Drugs.)
Databáze: MEDLINE
Externí odkaz: